THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE

被引：0
|
作者：
Palmaro, A. [1 ]
Despas, F. [1 ]
Lapeyre-Mestre, M. [1 ,2 ]
机构：
[1] CHU Toulouse, Univ Hosp, Med & Clin Pharmacol Unit, Toulouse, France
[2] Univ Toulouse, INSERM 1027, Pharmacoepidemiol Res Unit, Toulouse, France
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E65 / E65
页数：1
相关论文
共 50 条
  • [41] EDA-V in advanced multiple myeloma patients previously treated with thalidomide
    Polloni, C.
    Offidani, M.
    Corvatta, L.
    Piersantelli, M. N.
    Catarini, M.
    Brunori, M.
    Alesiani, F.
    Burattini, M.
    Leoni, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 146
  • [42] INFECTION COMPLICATIONS IN AN UNSELECTED COHORT OF PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE COMBINATIONS
    Caravita, T.
    Offidani, M.
    Siniscalchi, A.
    Gentili, S.
    Caraffa, P.
    Perrotti, A.
    De Fabritiis, D.
    Leoni, P.
    HAEMATOLOGICA, 2012, 97 : 612 - 612
  • [43] Prognostic value of selected chromosomal abnormalities in multiple myeloma patients treated by thalidomide
    Zaoralova, R.
    Greslikova, H.
    Filkova, H.
    Nemec, P.
    Kuglik, P.
    Oltova, A.
    Pour, L.
    Adam, Z.
    Krivanova, A.
    Krejci, M.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 170 - 170
  • [44] Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
    Phoebe A. Huang
    Shaunna L. Beedie
    Cindy H. Chau
    David J. Venzon
    Sheryl Gere
    Dickran Kazandjian
    Neha Korde
    Sham Mailankody
    Ola Landgren
    William D. Figg
    Scientific Reports, 9
  • [45] Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews
    Visacri, Manlia Berlofa
    Ribeiro, Mayra Carvalho
    Komoda, Denis Satoshi
    Duarte, Bruno Kosa Lino
    Correa, Carlos Roberto Silveira
    Maia, Flavia de Oliveira Motta
    Alves, Daniela Fernanda dos Santos
    VALUE IN HEALTH REGIONAL ISSUES, 2024, 43
  • [46] The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea
    Kim, Cheolsu
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je Jung
    Kim, Kihyun
    Yoon, Dok Hyun
    Eom, Hyeon Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (05): : 675 - 683
  • [47] Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
    Larocca, Alessandra
    Cavallo, Federica
    Bringhen, Sara
    Di Raimondo, Francesco
    Falanga, Anna
    Evangelista, Andrea
    Cavalli, Maide
    Stanevsky, Anfisa
    Corradini, Paolo
    Pezzatti, Sara
    Patriarca, Francesca
    Cavo, Michele
    Peccatori, Jacopo
    Catalano, Lucio
    Carella, Angelo Michele
    Cafro, Anna Maria
    Siniscalchi, Agostina
    Crippa, Claudia
    Petrucci, Maria Teresa
    Ben Yehuda, Dina
    Beggiato, Eloise
    Di Toritto, Tommaso Caravita
    Boccadoro, Mario
    Nagler, Arnon
    Palumbo, Antonio
    BLOOD, 2012, 119 (04) : 933 - 939
  • [48] Neuropathy in multiple myeloma treated with thalidomide - A prospective study
    Plasmati, R.
    Pastorelli, F.
    Cavo, M.
    Petracci, E.
    Zamagni, E.
    Tosi, P.
    Cangini, D.
    Tacchetti, P.
    Salvi, F.
    Bartolomei, I.
    Michelucci, R.
    Tassinari, C. A.
    NEUROLOGY, 2007, 69 (06) : 573 - 581
  • [49] Phase II Trial of Syncopated Thalidomide, Lenalidomide, and Weekly Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
    Tufail, Madiha
    Siegel, David S.
    McBride, Laura
    Bilotti, Elizabeth
    Bello, Erica
    Anand, Palka
    Olivo, Karly
    Bendarz, Urszula
    McNeill, Ann
    Vesole, David H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (03): : 186 - 190
  • [50] Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
    Guglielmelli, T.
    Bringhen, S.
    Rrodhe, S.
    Gay, F.
    Cavallo, F.
    Berruti, A.
    Montefusco, V.
    Piro, E.
    Benevolo, G.
    Petrucci, M. T.
    Caravita, T.
    Offidani, M.
    Corradini, P.
    Boccadoro, M.
    Saglio, G.
    Palumbo, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (06) : 814 - 818
12345